You Position: Home > Paper

Significance of urine BLCA-4 immunoassay in the postoperative surveillance and prognosis evaluation of non-muscle invasive bladder cancer

( views:259, downloads:64 )
Author:
No author available
Journal Title:
Chinese Journal of Biomedical Engineering
Issue:
2
DOI:
10.3760/cma.j.issn.1674-1927.2017.02.010
Key Word:
膀胱癌特异性核基质蛋白4;酶联免疫吸附测定;肿瘤复发;预后;Bladder cancer specific nuclear matrix protein 4;Enzyme-linked immunosorbent assay;Neoplasm recurrence;Prognosis

Abstract: Objective To investigate the significance of urine bladder cancer specific nuclear matrix protein 4(BLCA-4)immunoassay in postoperative surveillance and prognosis evaluation of non-muscle invasive bladder cancer(NMIBC). Methods From December 2013 to June 2015,42 patients with bladder cancer registered in our department underwent transurethral electrocision of the bladder cancers,and were confirmed to have NMIBC by postoperative pathological study. The levels of urine BLCA-4 were measured before and at 1, 3,6 and 12 months after operation. The recurrence of tumor was monitored monthly by cystoscopy. The relationship between preoperative urine BLCA-4 level and clinicopathological parameters was analyzed. Multivariate COX regression analysis was performed to determine the risk factors for postoperative recurrence of NMIBC. Results The level of urine BLCA-4 in 42 patients reached the nadir at 1 month and gradually increased at 3 months after operation. Elevated urine BLCA-4 levels were noted before cystoscopic confirmation in all patients with recurrence of NMIBC. Positivity of urine BLCA-4 was noted up to(8.1±3.5)months earlier than the confirmation by cystoscopy in these patients. Preoperative urine BLCA-4 level were correlated with tumor grading and clinical staging(both P<0.05). Multivariate COX regression analysis showed that preoperative over-expression of urine BLCA-4,and positivity in urine BLCA-4 at 3 and 6 postoperative months were risk factors for NMIBC recurrence(all P<0.05).Conclusion Measurement of urine BLCA-4 level is helpful for postoperative surveillance and prognosis evaluation of NMIBC.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn